Genprex Inc (GNPX)

09:51 AM

Genprex, Inc. Announces Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting - marketscreener.com

09:51 AM

09:14 AM

Genprex reports biomarker data from lung cancer gene therapy study By Investing.com - Investing.com Nigeria

09:14 AM

09:06 AM

Genprex reports biomarker data from lung cancer gene therapy study - Investing.com

09:06 AM

08:03 AM

Biomarker data link Trop-2 to PFS in Genprex (NASDAQ: GNPX) trials - Stock Titan

08:03 AM

08:00 AM

Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting - PR Newswire

08:00 AM

May 22, 2026

Genprex Inc. (GNPX) Edges Higher Amid Biotech Sector Cautious ToneLow Vol Factor - Newser

May 22, 2026

May 22, 2026

GNPX Should I Buy - Intellectia AI

May 22, 2026

May 21, 2026

Genprex (GNPX) Q1 2026 Earnings Stay the Course — EPS $-0.64Retail Trader Picks - Newser

May 21, 2026

May 18, 2026

Why Is Genprex, Inc. (GNPX) Stock Down Today? - Meyka

May 18, 2026

May 14, 2026

Genprex (GNPX) Showcases Promising Diabetes Gene Therapy Results - GuruFocus

May 14, 2026

May 14, 2026

Genprex, Inc. Files Form 8-K With SEC – Company Information and Filing Details for May 14, 2026 - Minichart

May 14, 2026

May 14, 2026

Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting - BioSpace

May 14, 2026

May 14, 2026

Genprex Announces Positive Preclinical Data for Diabetes Gene Therapy - TipRanks

May 14, 2026

May 14, 2026

Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT - TradingView

May 14, 2026

May 14, 2026

Genprex collaborators present diabetes gene therapy data - Investing.com

May 14, 2026

May 14, 2026

Genprex collaborators present diabetes gene therapy data By Investing.com - Investing.com UK

May 14, 2026

May 14, 2026

[8-K] Genprex, Inc. Reports Material Event - Stock Titan

May 14, 2026

May 13, 2026

Genprex, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 13, 2026

May 13, 2026

Genprex (NASDAQ: GNPX) raises cash through share sales amid going concern risk - Stock Titan

May 13, 2026

May 11, 2026

Genprex (GNPX) warrant holders report 249,788 shares, 2.69% stake - Stock Titan

May 11, 2026

May 10, 2026

Number of shareholders of Genprex Inc – LSE:0A8I - TradingView

May 10, 2026

May 08, 2026

GNPX (Genprex) Q1 loss narrower than expected, beating estimates by 37.8% despite zero revenue and shares ticking higher.Miss Estimates - newser.com

May 08, 2026

May 06, 2026

Top 3 Health Care Stocks That Are Set To Fly In Q2 - Benzinga

May 06, 2026

May 05, 2026

GNPX Forecast, Price Target & Analyst Ratings | GENPREX INC (NASDAQ:GNPX) - ChartMill

May 05, 2026

May 03, 2026

MSN Money - MSN

May 03, 2026

May 01, 2026

Genprex, Inc. Files Form 8-K With SEC: Company Information, Nasdaq Listing, and Regulatory Details - Minichart

May 01, 2026

Apr 30, 2026

Genprex Secures Patent for Reqorsa Gene Therapy in Cancer Treatm - GuruFocus

Apr 30, 2026

Apr 30, 2026

Genprex Expands Reqorsa Cancer Therapy Patent Protection in Israel - TipRanks

Apr 30, 2026

Apr 30, 2026

Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer - BioSpace

Apr 30, 2026

Apr 30, 2026

Genprex | 8-K: Current report - Moomoo

Apr 30, 2026

Apr 30, 2026

Israel grants Genprex (NASDAQ: GNPX) patent for REQORSA lung cancer use - Stock Titan

Apr 30, 2026

Apr 29, 2026

Genprex (NASDAQ: GNPX) seeks approval for equity plan and reverse stock split - Stock Titan

Apr 29, 2026

Apr 29, 2026

Genprex collaborators to present diabetes gene therapy data at May meeting By Investing.com - Investing.com Australia

Apr 29, 2026

Apr 28, 2026

Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting - BioSpace

Apr 28, 2026

Apr 28, 2026

Genprex collaborators to present diabetes gene therapy data at May meeting - Investing.com UK

Apr 28, 2026

Apr 28, 2026

average down - Moomoo

Apr 28, 2026

Apr 28, 2026

Genprex Highlights Promising Preclinical Data for Diabetes Gene Therapy - TipRanks

Apr 28, 2026

Apr 28, 2026

Genprex (GNPX) shows GPX-002 gene therapy reversed hyperglycemia in T2D mice - Stock Titan

Apr 28, 2026

Apr 23, 2026

Genprex biomarker research selected for ASCO 2026 meeting By Investing.com - Investing.com India

Apr 23, 2026

Apr 22, 2026

Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy To Be Released at the 2026 ASCO Annual Meeting - StreetInsider

Apr 22, 2026

Apr 22, 2026

Genprex biomarker research selected for ASCO 2026 meeting - Investing.com

Apr 22, 2026

Apr 22, 2026

Lung cancer gene therapy study lands ASCO slot with biomarker data - Stock Titan

Apr 22, 2026

Apr 22, 2026

Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therapy - The Malaysian Reserve

Apr 22, 2026

Apr 22, 2026

Genprex signs research deal to study lung cancer biomarkers By Investing.com - Investing.com India

Apr 22, 2026